Li Kun-Kun, Bao Tao, Wang Ying-Jian, Zhao Xiao-Long, Long Jiang, Xie Xian-Feng, Guo Wei
Department of Thoracic Surgery, Daping Hospital, Army Medical University, Chongqing, China.
Front Oncol. 2022 Mar 11;12:834552. doi: 10.3389/fonc.2022.834552. eCollection 2022.
The prognostic benefit of extensive lymphadenectomy remains controversial in esophageal squamous cell carcinoma (ESCC). The purpose of this retrospective study was to investigate the potential effect of solitary mediastinal (SM) lymph node metastasis and solitary celiac (SC) lymph node metastasis on the short- and long-term outcomes for patients who underwent minimally invasive McKeown esophagectomy.
From September 2009 to December 2020, a total of 934 cases were diagnosed with ESCC and underwent minimally invasive McKeown esophagectomy in our department; 223 cases met the inclusion and exclusion criteria. Propensity score matching (PSM) was utilized to contrast the postoperative results and long-term survival of Group 1 (SM) and Group 2 (SC). Univariate and multivariate Cox proportional hazards regression analyses were used on possible predictors of survival.
One hundred forty-seven patients were available for outcome comparison after PSM. The postoperative results were not significantly different between the two groups. In terms of long-term survival, the 5-year disease-free survival (DFS) was 37.6% and 57.3% ( = 0.191) and 5-year disease-specific survival (DSS) was 39.7% and 68.4% ( = 0.028) for Group 1 (SM) and Group 2 (SC), respectively. Univariate and multivariate Cox proportional hazards regression analyses showed that body mass index (BMI), pathologic stage (pStage), and SC/SM grouping had significant hazard ratios (HRs), which suggested that SC is associated with better DSS.
This cohort study showed that SC lymph node metastasis has a better long-term survival compared with SM lymph node metastasis in esophagectomy of ESCC. The results challenge the current understanding and need confirmation in further research.
在食管鳞状细胞癌(ESCC)中,广泛淋巴结清扫术的预后益处仍存在争议。本回顾性研究的目的是探讨孤立性纵隔(SM)淋巴结转移和孤立性腹腔干(SC)淋巴结转移对接受微创McKeown食管切除术患者短期和长期预后的潜在影响。
2009年9月至2020年12月,共有934例ESCC患者在我科诊断并接受了微创McKeown食管切除术;223例符合纳入和排除标准。采用倾向评分匹配(PSM)对比第1组(SM)和第2组(SC)的术后结果和长期生存情况。对生存的可能预测因素进行单因素和多因素Cox比例风险回归分析。
PSM后有147例患者可进行预后比较。两组术后结果无显著差异。在长期生存方面,第1组(SM)和第2组(SC)的5年无病生存率(DFS)分别为37.6%和57.3%(P = 0.191),5年疾病特异性生存率(DSS)分别为39.7%和68.4%(P = 0.028)。单因素和多因素Cox比例风险回归分析显示,体重指数(BMI)、病理分期(pStage)和SC/SM分组具有显著的风险比(HRs),这表明SC与更好的DSS相关。
本队列研究表明,在ESCC食管切除术中,SC淋巴结转移比SM淋巴结转移具有更好的长期生存。结果挑战了当前的认识,需要进一步研究予以证实。